Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice  by Buijs, J. et al.
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01503.x
Pathophysiology of in-vitro induced ﬁlaments, spheroplasts and
rod-shaped bacteria in neutropenic mice
J. Buijs1,2, A. S. M. Dofferhoff1,3, J. W. Mouton1 and J. W. M. van der Meer4,5
1Department of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital,
Nijmegen, 2Department of Internal Medicine, Atrium Medical Centre, Heerlen, 3Department of
Internal Medicine, Canisius-Wilhelmina Hospital, 4University Centre for Infectious Diseases and
5Department of General Internal Medicine, University Medical Centre, Nijmegen, The Netherlands
ABSTRACT
This study compared the in-vitro properties and in-vivo effects of Escherichia coli ﬁlaments, spheroplasts
and normal cells in a murine thigh infection model. E. coli was exposed to ceftazidime, meropenem or
saline to obtain ﬁlaments, spheroplasts or normal bacilli, which were then injected into neutropenic
mice. After 24 h, morphology, CFUs, local and circulating endotoxin levels, cytokine levels and
mortality were recorded, and correlations between bacterial and host parameters of infection were
investigated. Filaments and spheroplasts contained more endotoxin ⁄CFU than controls. Histological
studies showed that morphologically altered bacteria changed into rod-shaped cells in the absence of
antibiotics. Bacterial spread to the liver was signiﬁcantly higher in mice challenged with rod-shaped
cells, compared with antibiotic-exposed bacteria (p 0.007). Muscle endotoxin levels correlated signiﬁ-
cantly with circulating interleukin (IL)-6 and tumour necrosis factor (TNF)-a, and both pro-
inﬂammatory cytokines were correlated signiﬁcantly (p 0.011). Despite a tendency toward higher local
and systemic concentrations of endotoxin in the ﬁlament group, inﬂammatory responses and survival
did not differ between groups. It was concluded that morphologically altered bacteria contain more
endotoxin and can regain a rod shape after withdrawal of antibiotics, while non-antibiotic-exposed
bacteria show greater spread to the liver. There was a clear intra-individual relationship between local
endotoxin, systemic endotoxin, TNF-a and IL-6 production, but these parameters did not differ among
groups.
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INTRODUCTION
Endotoxin, or lipopolysaccharide, released from
the bacterial cell wall is the most important
mediator in the pathogenesis of Gram-negative
sepsis [1–10]. Endotoxin release initiates a com-
plex cascade involving production of endogenous
mediators by the immune system of the host. The
most important pro-inﬂammatory mediators are
tumour necrosis factor (TNF)-a, interleukin (IL)-1,
and IL-6 [11]. In low concentrations, these cyto-
kines augment host defence [12–14]. However,
exaggerated release, which can be triggered by
an overload of endotoxin, can cause pathophys-
iological effects resulting in shock and death
[15–18]. Shenep et al. [19] demonstrated an exag-
gerated release of endotoxin after bacterial
exposure to cell-wall-active antibiotics, but this
response was absent when rapidly acting bacte-
ricidal agents were used. In addition, other
investigators have shown variations in endotox-
in-liberating capacity among different b-lactam
antibiotics [10,20,21].
Penicillin-binding proteins (PBPs) are enzymes
anchored in the cytoplasmic membranes of bac-
teria. PBPs, particularly PBP1, PBP2 and PBP3,
have signiﬁcant biological functions, including
determination of cell shape, phage resistance,
induction of capsule synthesis, and regulation
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of autolysis [15,22–24]. During exposure of
Gram-negative bacteria to low ceftazidime con-
centrations, PBP3 inhibition occurs, leading to
formation of bacterial ﬁlaments. It has been
shown previously that bacterial ﬁlaments are
capable of releasing large amounts of endotoxin
from their cell walls in vitro [22]. PBP2 inhibition,
which occurs during meropenem exposure, leads
to formation of spheroplasts [25].
In contrast to ﬁlaments, spheroplasts contain
lower endotoxin concentrations, comparable to
those of rod-shaped cells [24,26]. On the basis of
these observations, it is possible that antibiotic-
induced ﬁlament formation, in contrast to sphero-
plast formation, may have adverse clinical effects
because of excessive endotoxin release. To test
this hypothesis, the present study challenged
neutropenic mice with ﬁlaments, spheroplasts or
rod-shaped Escherichia coli cells in a murine thigh
muscle model of infection [27–29]. The in-vitro
properties of the different inocula were studied
with respect to morphology and the endotoxin
content ⁄CFU, local growth, local and systemic
endotoxin concentrations, morphology and sys-
temic spread. Finally, the mortality rate and the
plasma concentrations of the pro-inﬂammatory
cytokines TNF-a and IL-6 were determined, as
parameters of both clinical effects and host
defence [11,14,17,30].
MATERIALS AND METHODS
Mice
Female outbred Swiss mice (aged 6–8 weeks, weight 20–
30 g) were used for the experiments. Mice were bred by
Harlan (Horst, The Netherlands) and arrived at the Central
Animal Laboratory 2 weeks before the start of the experi-
ments. Mice were held in a speciﬁc pathogen-free unit in
ﬁlter-top cages with beds of sterilised sawdust. Food (Hope
Farms, Woerden, The Netherlands) and acidiﬁed water were
supplied ad libitum. The temperature was kept at 20–24C,
with a relative humidity of 50–60%, 15 air changes ⁄h, and
light and dark periods of 14 and 10 h, respectively. All
experiments were approved by the Ethical Committee on
Animal Experiments of the University Medical Centre
Nijmegen, The Netherlands.
Induction of neutropenia and anaesthesia
On day minus 4, all mice received cyclophosphamide (End-
oxan-ASTA; Dagra, Diemen, The Netherlands) 150 mg ⁄ kg
subcutaneously to induce neutropenia. On day minus 1, a
second dose of 100 mg ⁄kg was given. Leukocyte counts and
differentiation conﬁrmed a neutropenia of < 0.1 · 106 leuko-
cytes ⁄L in each of the eight mice examined. During injections,
the mice were anaesthetised with ether.
Microorganisms
E. coli strain ATCC 25922 was used for all experiments. The
MICs of ceftazidime and meropenem for this strain were 0.25
and 0.025 mg ⁄L, respectively, as determined by Etest and
broth microdilution methods [31,32]. Bacteria were stored at
) 80C and subcultured on blood agar 2 days before the
experiment. Subsequently, two colonies were inoculated into
10 mL of Mueller–Hinton broth and incubated overnight to
obtain a culture containing c. 3 · 108 CFU ⁄mL; this was
diluted in triplicate with Mueller–Hinton broth in pyrogen-
free glass test tubes to a concentration of 1 · 106 CFU ⁄mL.
After mixing, either ceftazidime, meropenem or saline was
added (see below); this was followed by incubation for 4 h to
induce ﬁlaments, spheroplasts or normal-shaped bacilli,
respectively. Before injection, bacterial suspensions were
mixed, diluted 1:10, washed twice and resuspended in saline
at 37C.
Antibiotics
Ceftazidime (Glaxo SmithKline, Zeist, The Netherlands) and
meropenem (AstraZeneca, Zoetermeer, The Netherlands) were
used at concentrations of 0.125 and 0.0125 mg ⁄L, respectively
(0.5 · MIC, for both drugs) to induce in-vitro morphological
changes with a minimum effect on bacterial growth. An
aliquot (25 lL) of either a ceftazidime 0.05 mg ⁄mL solution or
a meropenem 0.005 mg ⁄mL solution was added to a test tube
containing 10 mL of E. coli suspension. After discarding the
same volume from the test solution, a ceftazidime concentra-
tion of 0.125 mg ⁄L or a meropenem concentration of
0.0125 mg ⁄mL was obtained. In a control tube, 25 lL of the
bacterial suspension was discarded and replaced with 25 lL of
saline.
Blood and tissue collection
Blood specimens were collected from the retro-orbital plexus
by eye extraction and were stored in sterile pyrogen-free
Falcon tubes (Becton Dickinson, Franklin Lakes, NJ, USA).
These tubes contained 10 lL of a 5000 U ⁄mL pyrogen-free
heparin solution (Leo Pharmaceutical Products, Weesp, The
Netherlands). The tubes were placed immediately on ice and
then centrifuged for 5 min to obtain plasma samples.
Undiluted plasma was collected in Eppendorf tubes and
frozen at ) 80C until the cytokine levels were determined.
Plasma (0.5 mL) was aspirated in a sterile, pyrogen-free
syringe (Monoject; Kendall, Ballymoney, Northern Ireland),
diluted 1:10 in saline, and stored in pyrogen-free Falcon
tubes at ) 80C until limulus amoebocyte assays could be
performed. Liver, spleen and thigh muscles were removed
aseptically, immersed in saline, weighed, and then homo-
genised in a tissue grinder. Serial dilutions of homogenised
tissues were plated on sheep blood agar. After overnight
incubation at 37C, the number of CFU ⁄g tissue was
calculated.
Endotoxin assay
Endotoxin concentrations in plasma and muscle were deter-
mined by a chromogenic limulus amoebocyte assay (KabiVi-
trum, Amsterdam, The Netherlands), according to the manu-
facturer’s instructions, at the Laboratory of Haematology,
University Hospital Groningen, The Netherlands.
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TNF-a and IL-6
Circulating TNF-a was detected by a radioimmunoassay
developed and validated locally, and IL-6 concentrations were
determined by ELISA (Biosource International, Camarillo, CA,
USA). The detection limits of the two assays were 40 pg ⁄mL
and 30 pg ⁄mL, respectively.
Effects of changes in morphology
Changes in the length of ﬁlaments and the shape of sphero-
plasts during the in-vitro part of the study were determined
following Gram’s stain. In-vivo morphology after 24 h was
assessed in haematoxylin–eosin-stained histological sections of
muscle, liver and spleen, using light microscopy with magni-
ﬁcations of · 400 and · 1000. The effects of centrifugation,
dilution, and the washing and mixing steps on morphology
during the preparation of inocula were checked by examining
Gram’s stains of cells at several time-points during the
procedure. Bacterial counts, endotoxin content and the rela-
tionship between these parameters in inocula were also
studied. In addition, initial test suspensions containing 105
and 106 CFU ⁄ inoculum of E. coli bacilli (eight mice for each
inoculum size), and 104 and 105 CFU ⁄ inoculum of E. coli
ﬁlaments (four mice for each inoculum size) were used to
deﬁne the inoculum size required to obtain mice with a severe
sepsis and 100% survival after 24 h. The effectiveness of
cyclophosphamide for the induction of neutropenia was
checked by measuring leukocyte counts and differentiation
using light microscopy of blood smears from eight mice.
Sepsis and mortality studies
On each test day, 12 neutropenic mice were randomised
between inoculation into the left thigh muscle with 0.1 mL of
ﬁlament solution, 0.1 mL of spheroplast solution, or 0.1 mL of
control solution. In each experiment, four mice per group were
investigated. The mice were kept in cages for 24 h following
inoculation, and then anaesthetised with ether and killed.
Immediately thereafter, blood was collected from the retro-
orbital plexus for endotoxin and cytokine assays. Liver, spleen
and thigh muscles were removed surgically, homogenised and
plated on agar to determine bacterial counts. Parts of the
homogenates of thigh muscles were stored in pyrogen-free
tubes for endotoxin assays. The experiments were performed
in duplicate on two separate days.
In a separate experiment, mortality was investigated in 12
mice. Mice were randomised between inoculation with bac-
terial ﬁlaments, spheroplasts or rod-shaped cells in thigh
muscles, and then kept in cages and observed until death
occurred.
Statistical analysis
Statistical analysis was performed using the SPSS v.10.0
package for Windows (SPSS Inc., Chicago, IL, USA) and
GraphPad Prism v.3.0 (GraphPad Software Inc., San Diego,
CA, USA). Levene’s test for equality of variances was used to
determine whether parameters were distributed normally.
Differences in viable counts, survival, endotoxin concentra-
tions and cytokine concentrations were analysed by multiva-
riate analysis (ANOVA) for normally distributed parameters,
followed, when appropriate, by post-hoc t-tests. Parameters
without a normal distribution were analysed with the
non-parametric Kruskal–Wallis test, followed by the Mann–
Whitney test to investigate differences among groups.
Correlations among parameters with a normal distribution
were determined with the Pearson correlation test. For
non-normally distributed parameters, the non-parametric
Spearman’s rank correlation test was applied. Statistical tests
were considered signiﬁcant at p < 0.05.
RESULTS
Comparison of ﬁlaments, spheroplasts and
normal E. coli cells in vitro
Incubation with ceftazidime resulted in the
formation of ﬁlaments, whereas exposure to
meropenem resulted in 100% formation of
spheroplasts. Morphological studies demonstrat-
ed ﬁlaments with a length of four to eight cells
after the centrifugation, dilution and mixing
procedures. The morphology of the spheroplasts
and controls did not change during these proce-
dures.
Table 1 summarises the viable counts, endo-
toxin concentrations and ratios of endotoxin ⁄CFU
for ﬁlaments, spheroplasts and controls, respect-
ively. From these data, it was calculated that
ﬁlaments and spheroplasts contain 13.49-fold and
5.36-fold, respectively, more endotoxin ⁄CFU than
normal cells. Assuming that the characteristics of
ﬁlaments are equivalent to those of rod-shaped
cells, it was expected that the amount of endo-
toxin ⁄CFU (· 1000) would vary between 9.52 and
19.04 (4 · 2.38 and 8 · 2.38, respectively), after
taking into account the fact that the length of one
ﬁlament was the length of between four and eight
normal cells; however, the actual value was up to
3.4-fold higher than expected.
Survival studies
When eight neutropenic mice were challenged
intra-muscularly with 1 · 106 CFU of normal
E. coli, only one mouse survived for 24 h (a
survival rate of 12.5%). Challenge of eight mice
Table 1. CFUs, endotoxin levels and the relationship
between these two parameters for different cell-type
inocula
Inoculum CFU ⁄mL
Endotoxin
(U ⁄mL)
Ratio endotoxin ⁄
CFU (U ⁄CFU · 1000)
Filaments 8.1 · 104 2600 ± 24.1 32.10
Spheroplasts 9.8 · 104 1250 ± 74.9 12.76
Controls 6.3 · 105 1500 ± 6.6 2.38
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with an inoculum of 105 CFU of normal E. coli
resulted in 100% survival after 24 h. Similarly,
challenge of four mice with either 104 or 105 CFU
of E. coli ﬁlaments resulted in 100% survival after
24 h. On the basis of these ﬁndings, a maximum
inoculum of 105 CFU ⁄mouse was chosen for
controls in further experiments.
In the main survival experiment, the survival
times of infected mice were 42.25 h (SD 9.5, range
28–47 h), 41.25 h (SD 9.5, range 28–47 h) and
42.25 h (SD 11.5, range 24–47 h) for ﬁlament-
exposed, spheroplast-exposed and control mice,
respectively, with 100% mortality after 47 h,
irrespective of the group. Thus, at the time when
measurements were performed in the sepsis
studies, the mice were suffering from a severe
sepsis, leading to death within 24 h from that
time-point.
Sepsis studies
At 24 h after inoculation, bacteria were identiﬁed
readily in the perivascular and perineural spaces
in haematoxylin–eosin-stained thigh muscle sec-
tions. However, despite injection of ﬁlaments,
only normal-shaped Gram-negative bacilli were
observed. No bacteria were identiﬁed in histolog-
ical sections of liver and spleen using light
microscopy, despite bacterial counts of
104)106 CFU ⁄ g of tissue, perhaps because of the
architecture of these tissues.
Fig. 1 shows the bacterial counts in muscle,
liver and spleen at 24 h after inoculation with
normal bacilli, ﬁlaments or spheroplasts. CFUs in
liver tissue showed signiﬁcant differences be-
tween groups (p 0.025), with the highest CFUs in
liver homogenates from controls. There were also
signiﬁcant differences between spheroplasts and
controls (p 0.015), between ﬁlaments and controls
(p 0.027), and between all antibiotic-exposed bac-
teria and controls (p 0.007). Although the same
trend of lower CFU counts was seen in spleen
tissue infected with spheroplasts, the bacterial
counts did not differ signiﬁcantly among groups
(p 0.1644). Similarly, no signiﬁcant differences in
viable counts were observed after 24 h in thigh
muscles. CFUs in muscle, liver and spleen did not
show signiﬁcant correlations with local or sys-
temic levels of endotoxin, TNF-a or IL-6.
Plasma and muscle endotoxin concentrations
are shown in Table 2. Although mean values
suggest higher endotoxin concentrations in the
plasma and muscle of mice injected with ﬁla-
ments, the differences among groups did not
reach signiﬁcance (p 0.063 for ﬁlaments vs.
spheroplasts). However, there was considerable
variation in the local endotoxin levels, reﬂected in
large standard deviations. Nevertheless, signiﬁ-
cant correlations could be shown between plasma
and muscle endotoxin levels (p 0.014).
Also shown in Table 2 are the mean levels of
plasma TNF-a and IL-6. Although these did not
differ among groups, there was a signiﬁcant
correlation between muscle endotoxin and plas-
ma IL-6 levels (p 0.025), and between muscle
endotoxin and TNF-a levels (p 0.03). There was
no signiﬁcant correlation between plasma endo-
toxin and IL-6 or TNF-a levels (p 0.074 and p 0.09,
respectively). There was a signiﬁcant correlation
between plasma TNF-a and IL-6 levels (p 0.011).
DISCUSSION
The in-vitro part of this study demonstrated a
higher endotoxin content ⁄CFU in antibiotic-
exposed bacteria than in controls. In contrast to
previous ﬁndings, this study also demonstrated
higher endotoxin contents in spheroplasts [24,26].
This could be caused by the induction of sphero-
plasts with meropenem, which binds to PBP2 and
PBP3. In previous studies [24], imipenem, which
binds to PBP1 and PBP2, was used to induce
spheroplasts. Thus, it is possible that the toxic
properties of spheroplasts may differ according to
Fig. 1. Mean bacterial counts (CFU ⁄ g) and standard devi-
ations in murine thigh muscle, liver and spleen at 24 h
after inoculation with different bacterial cell types.
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the inducing antibiotic and its afﬁnity for speciﬁc
PBPs. The study also revealed that the higher
endotoxin content of ﬁlaments could not be
explained simply by normal bacterial growth
without septation. It is not clear whether a higher
density of endotoxin molecules in the cell wall, a
larger cell surface, or a change in the endotoxin
molecule itself, contributed to these higher than
expected endotoxin levels. However, the ﬁndings
correlate with those of Jackson and Kropp [33] for
Pseudomonas isolates exposed to sub-MIC concen-
trations of ceftazidime.
The present model showed that ﬁlaments were
able to regain normal shapes after withdrawal of
antibiotics. However, there was a difference in the
dissemination pattern of bacteria during the ﬁrst
24 h of sepsis, even though local bacterial counts
in thighs were equal after 24 h. Dissemination of
bacteria to the liver occurred signiﬁcantly more
efﬁciently in the group infected with rod-shaped
cells, compared with the groups infected with
antibiotic-exposed bacteria. Differences in the
systemic spread of morphologically altered
microorganisms may be explained by differences
in size or changes in the vitality of bacteria,
causing inhibition of migration of the larger
forms. Chen et al. [34] have described altered
motility of Burkholderia pseudomallei following
exposure to ﬁlament-inducing antibiotics. A sec-
ond explanation could involve a greater vulner-
ability of morphologically altered bacteria to host
defence mechanisms, e.g., differences in serum
bactericidal effect. The fact that no signiﬁcant
difference in spread to spleen tissue was detected
might be explained by the overwhelming num-
bers of CFUs in spleen tissue masking more subtle
differences.
Antibiotic-induced morphological changes, and
changes in dissemination of E. coli, did not affect
parameters of severity of infection and survival,
perhaps because the bacteria were able to septate
again after the withdrawal of the antibiotics, and
thus regained the morphological characteristics,
and probably the pathogenicity, of controls. Fur-
thermore, the numbers of CFUs in thighs were the
same in all groups after 24 h. Alternatively, the
infection may be so severe that a relatively low
endotoxin content associated with the natural
forms of E. coli may already have a maximum
effect. In all groups, the animals developed a
severe infection within the ﬁrst 24 h, leading to
death within 48 h of the start of the experiment.
The relative resistance of mice to endotoxin could
also be an explanation; thus, the amounts of
endotoxin associated with the various morpholo-
gical forms might not have contributed to death.
Finally, it is also possible that endotoxin is
retained in the membranes of ﬁlaments, i.e.,
locally at the site of infection, for a longer period
of time, thus exposing the host to toxic molecules
to a lesser extent.
The study showed a clear relationship between
muscle and plasma endotoxin concentrations, and
between local endotoxin concentrations and cir-
culating levels of IL-6 and TNF-a. Although local
and circulating endotoxin levels were related
signiﬁcantly, the correlation between plasma
endotoxin levels and both cytokines did not reach
signiﬁcance. However, multiple plasma factors,
e.g., protein binding, might inﬂuence the concen-
tration and clearance of circulating lipopolysac-
charide. The relationship between endotoxin and
cytokines has been investigated in other models
and in human studies [17,35–40]. It will be
interesting to focus further studies with the model
on the inﬂammatory responses that occur during
the ﬁrst hours after inoculation, and on the host
reactions to milder infections, in order to investi-
gate more subtle differences. Another valuable
use of the model might involve a situation in
which the presence of antibiotics is maintained for
longer, in order to keep the bacteria in their
altered shapes.
In conclusion, the in-vitro part of this study
conﬁrmed the ﬁnding that ﬁlaments contain more
endotoxin in their cell wall than do controls [41].
Table 2. Mean muscle endotoxin, plasma endotoxin, tumour necrosis factor (TNF)-a and interleukin (IL)-6 levels at 24 h
after inoculation of neutropenic mice with different bacterial cell types
Cell type
(number of mice)
Muscle LPS
(U ⁄mL) Mean (SD)
Plasma LPS
(U ⁄mL) Mean (SD)
Plasma TNF-a
(pg ⁄mL) Mean (SD)
Plasma IL-6
(pg ⁄mL) Mean (SD)
Filaments (n = 8) 262 363 (141 592) 91 (32) 288 (477) 18 229 (15 163)
Spheroplasts (n = 8) 139 670 (109 900) 31 (25) 268 (506) 29 229 (32 378)
Controls (n = 8) 253 213 (179 257) 66 (62) 120 (124) 37 183 (31 991)
LPS, lipopolysaccharide (endotoxin).
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However, in contrast with earlier ﬁndings,
spheroplasts also contained more endotoxin com-
pared with normal bacilli. Local endotoxin,
plasma endotoxin and pro-inﬂammatory cytokine
levels showed a clear correlation in the present
model, and endotoxin levels in muscle showed a
signiﬁcant correlation with plasma endotoxin
levels. From the present study of overwhelming
and rapidly fatal septicaemia, it is clear that
ﬁlaments and spheroplasts are potentially more
virulent and pathogenic than rod-shaped cells,
and that they are able to regain normal shapes
after withdrawal of antibiotic treatment. Bacteria
that have been in an altered morphological shape
show different dissemination characteristics.
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